Biallelic pathogenic SLC26A4 variants were detectedin 28.2 % (62 out of 220) of the patients included in the study.This rate of SLC26A4-associated hearing loss was one of thehighest among all populations in the world. Here, SLC26A4 is linked to hearing loss disorder.